Angiodynamics (ANGO) Net Cash Flow (2010 - 2026)

Angiodynamics has reported Net Cash Flow for 17 years, with the latest figure at -$4.0 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 56.57% year-over-year to -$4.0 million; the trailing twelve-month figure through Feb 2026 stood at -$8.0 million (up 76.13% YoY), and the FY2025 full-year result was -$20.6 million, down 165.67% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$4.0 million, down from $2.9 million in the prior quarter.
• The five-year high for Net Cash Flow was $17.6 million in Q1 2024, with the low at -$21.2 million in Q3 2024.
• Historically, Net Cash Flow has averaged $166470.6 across 5 years, with a median of $165000.0 in 2023.
• The largest YoY upside for Net Cash Flow was 10549.7% in 2024 against a maximum downside of 263.41% in 2024.
• Angiodynamics' Net Cash Flow stood at $5.1 million in 2022, then sank by 38.88% to $3.1 million in 2023, then plunged by 119.58% to -$611000.0 in 2024, then jumped by 582.49% to $2.9 million in 2025, then sank by 235.55% to -$4.0 million in 2026.
• The last three Net Cash Flow figures came in at -$4.0 million (Q1 2026), $2.9 million (Q4 2025), and -$17.3 million (Q3 2025), per Business Quant data.